🇺🇸 FDA
Patent

US 7141236

Methods and compositions for delivering macromolecules to or via the respiratory tract

granted A61KA61K9/0075A61K9/1075

Quick answer

US patent 7141236 (Methods and compositions for delivering macromolecules to or via the respiratory tract) held by Nektar Therapeutics expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
39
CPC classes
A61K, A61K9/0075, A61K9/1075, A61K9/127, A61K9/1617